Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 4151-80-8 | MDL No. : | MFCD00151795 |
Formula : | C12H12B2O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SLHKDOGTVUCXKX-UHFFFAOYSA-N |
M.W : | 241.84 | Pubchem ID : | 2734608 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 4.0 |
Molar Refractivity : | 71.53 |
TPSA : | 80.92 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.81 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 1.36 |
Log Po/w (WLOGP) : | -1.29 |
Log Po/w (MLOGP) : | 0.15 |
Log Po/w (SILICOS-IT) : | -1.72 |
Consensus Log Po/w : | -0.3 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.49 |
Solubility : | 0.78 mg/ml ; 0.00322 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.66 |
Solubility : | 0.527 mg/ml ; 0.00218 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.7 |
Solubility : | 0.479 mg/ml ; 0.00198 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.05 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64.5% | Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 1 h; Stage #2: With Trimethyl borate In tetrahydrofuran; hexane at -30 - 20℃; for 1 h; Stage #3: With hydrogenchloride In water |
To a solution of 4,4'-dibromo-l,l'-biphenyl (5. OOg, 16.03 mmol) in dry THF (100 mL) was added dropwise n-butylithium (1.0M solution in hexane, 40.1 mL, 64.1 mmol) at -78°C and stirred for Ihr. The reaction mixture was warm to -30°C and dropwise added trimethyl borate (4.83 mL, 43.3 mmol) and allowed to stir at room temperature for Ihr. Then the reaction mixture was acidified to pH=2 by 1.5 N HCl. The precipitate was filtered to obtained [l,l'-biphenyl]-4,4'-diyldiboronic acid (2.5 g, 10.34 mmol, 64.5 percent yield) as off white solid. NMR (DMSO-d6, δ = 2.50 ppm, 400 MHz): δ 8.06 (br. s., 4 H), 7.88 (d, J= 8.53 Hz, 4 H), 7.65 (d, J= 8.4 Hz, 4 H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42% | With potassium carbonate;tetrakis(triphenylphosphine) palladium(0); In ethanol; water; toluene; for 5h;Heating / reflux; | 4- {(2S, 3R)-1-(4-FLUOROPHENYL)-3-[(3S)-3-(4-FLUOROPHENYL)-3-HYDROXYPROPYL]-4- oxoazetidin-2-yl} phenyl trifluoromethanesulfonate (80.1 mg, 0.148 mmol) and tetrakis (TRIPHENYLPHOSPHINE) palladium (0) (8. 5 mg, 0.00736 mmol) were dissolved in toluene (1.0 ML). 2.0 M aqueous potassium carbonate (0.148 ML) and a solution of 4, 4'-biphenyldiboronic acid (17.9 mg, 0.074 mmol) in ethanol (0.5 mL) were added. The reaction was stirred vigorously for 5 h at refluxing temperature under a nitrogen atmosphere and then diluted with water (2.5 mL), extracted with ethyl acetate (3 X 10 mL), washed with brine (10 mL), dried over sodium sulfate, filtered, concentrated and purified by chromatography (12 g silica gel, 10% to 100% ethyl acetate-hexane) to afford (3R, 4S, 3 R, 4 S)-4, 4 -(1, 1 : 4', 1" : 4", 1" -QUATERPHENYL-4, 4" -DIYL) BIS F 1- (4- FLUOROPHENYL)-3- [ (3)-3- (4-FLUOROPHENYL)-3-HYDROXYPROPYL] AZETIDIN-2-ONE} 102 (58 mg, 42% yield) as an off-white solid. RF = 0.4, silica gel, 1: 1 ethyl ACETATE/HEXANES. NMR 1H (CDC13) 7.7-6. 9 (M, 32H), 4.7 (m, 2H), 4.6 (s, 2H), 3.2 (M, 2H), 2.1-1. 9 (M, 8H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
29% | With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In water; benzene; for 24h;Heating / reflux; | COMPARATIVE EXAMPLE 2Comparative Compound (B) shown below was prepared for comparison with Exemplifying compound (IV-10), a ?-conjugated compound of the present invention. The preparation process is described below.Tetrakis(triphenylphosphine)palladium (0.02 mmol) and 3 mL of an aqueous 2N sodium carbonate solution were added to a mixture liquid of 5,5-dibromo-3,4-dibutyl-3',4'-diperfluorobutyl-[2,2';5',2;5,2';5',2]quinquethiophene (1.0 mmol), 4,4'-biphenyl-bisboric acid (1.0 mmol), and 8 mL of benzene in a nitrogen atmosphere. The resulting mixture was refluxed for 24 hours. The reaction mixture was poured into a large amount of acetone to obtain a crude product. This crude product was purified by repeated reprecipitation to obtain the intended Comparative Compound (B) in a 29% yield. The obtained Comparative Compound (B) had a molecular weight of Mn: 21,300; Mw: 30,000 according to GPC measurement (solvent: chloroform).A field effect type organic transistor was prepared in the same manner as in Example 5 except that Comparative Compound (B) was used in place of Exemplifying compound (IV-10) used in Example 5. The mobility was measured in the same manner as in Example 4. The results are shown below. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In ethanol; water; toluene; for 3h;Heating / reflux; | (Example 2) [Production Method of Exemplified Compound No. 607](Intermediate 1-2)The following reagents and solvents were charged in a reaction vessel under nitrogen atmosphere, and a reaction solution was suspended. ?Intermediate 1-2: 305 mg (0.80 mmolj ?Biphenyl-4, 4' -diboronic acid: 92 mg (0.38 mmol) -Tetrakistriphenylphosphin palladium: 44 mg (0.04 mmol) ?Toluene: 9 ml ?Ethanol: 9 ml <n="67"/>10% sodium carbonate solution: 6 mlNext, the reaction solution was stirred for 3 hours under heating and reflux. After that, the reaction solution was cooled to room temperature, and water was added to terminate the reaction. Next, the solution was filtrated, and the resultant solid was purified by alumina column chromatography (developing solvent: chlorobenzene) . After that, the purified product was further subjected to slurry washing with chlorobenzene, and was filtered off, whereby 200 mg of Exemplified Compound No. 607 were obtained.Then, 754.2 as M+ of the compound was confirmed by Matrix Assisted Laser Desorption/Ionization - Time of Flight Mass Spectrometry (MALDI-TOFMS) . A PL spectrum in a toluene solution (1.0 * 10~5 mol/L) of Exemplified Compound No. 607 was measured. As a result, a PL spectrum shown in FIG. 7 was obtained. The PL spectrum was a blue emission spectrum having an emission peak at 441 nm and a full width at half maximum of 74 nm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64.5% | To a solution of 4,4'-dibromo-l,l'-biphenyl (5. OOg, 16.03 mmol) in dry THF (100 mL) was added dropwise n-butylithium (1.0M solution in hexane, 40.1 mL, 64.1 mmol) at -78C and stirred for Ihr. The reaction mixture was warm to -30C and dropwise added trimethyl borate (4.83 mL, 43.3 mmol) and allowed to stir at room temperature for Ihr. Then the reaction mixture was acidified to pH=2 by 1.5 N HCl. The precipitate was filtered to obtained [l,l'-biphenyl]-4,4'-diyldiboronic acid (2.5 g, 10.34 mmol, 64.5 % yield) as off white solid. NMR (DMSO-d6, delta = 2.50 ppm, 400 MHz): delta 8.06 (br. s., 4 H), 7.88 (d, J= 8.53 Hz, 4 H), 7.65 (d, J= 8.4 Hz, 4 H) |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
25% | With sodium hydrogencarbonate;dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; In water; isopropyl alcohol; at 20 - 150℃; for 0.216667h;microwave irradiation; | To a suspension of methyl N-[(1S)-1 -[(2S,4S)-2-(5-iodo-1 H-benzimidazol-2-yl)-4- methyl-pyrrolidine-1 -carbonyl]-2-methyl-propyl]carbamate (52.40 mg, 0.1082 mmol), methyl ((S)-1 -((2S,4S)-2-(4-iodo-1 H-imidazol-2-yl)-4-methylpyrrolidin-1 - yl)-3-methyl-1 -oxobutan-2-yl)carbamate (47 mg, 0.1082 mmol), [1 , 1 -biphenyl]- 4,4'-diyldiboronic acid (26.17 mg, 0.1082 mmol), Pd(DPPF)(Cl)2.CH2Cl2 (4.418 mg, 0.005410 mmol) and 1 mL of 2-propanol in a microwave vial is added 1M aqueous NaHC03 (541.0 muIota_, 0.5410 mmol). The reaction mixture is stirred for 3 minutes at room temperature and is heated to 150C in the microwave for 10 minutes. The reaction mixture is concentrated to dryness. The residue is purified by flash column chromatography on silica gel (0 to 10% methanol in CH2Cl2) and is further purified by reverse phase preparative HPLC to give ((S)-1 - {(2S,4S)-2-[5-(4'-{2-[(2S,4S)-1 -((S)-2-methoxycarbonylamino-3-methyl-butyryl)- 4-methyl-pyrrolidin-2-yl]-1 H-imidazol-4-yl}-biphenyl-4-yl)-1 H-benzoimidazol-2- yl]-4-methyl-pyrrolidine-1 -carbonyl}-2-methyl-propyl)-carbamic acid methyl ester (12 mg, 25%).LC/MS: m/z = 817.62 (M+H+). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
20% | With tetrabutylammomium bromide; palladium diacetate; sodium carbonate; In water; at 155℃; for 0.0833333h;Inert atmosphere; | To a solution of 6-bromo-N,N-diphenylnaphthalen-2-amine (1.0028 g, 2.65 mmols), 4,4'- diphenyldiboronic acid (0.3188 g, 1.32 mmols), sodium carbonate (0.87 g, 8 mmols), and TBAB (0.856 g) in water (6.1 mL) was added Pd(OAc)2 (0.035 g, 0.03 mmols). The solution was degassed with nitrogen, and heated to 155 C for 5 min. The reaction solution was then poured into ethyl acetate and water. A precipitate was filtered off and redissolved in hot toluene, and the organic layer was concentrated, and the crude product was chromatographed (2.5-100% ethyl acetate in hexanes, and then hot toluene, silica gel) to give the title compound (0.200 g, 20%>) as a yellow, crystalline compound: 1H NMR (400 MHz, CDC13) delta 8.03 (s, 2H), 7.77-7.83 (m, 10H), 7.74 (d, J= 8.8, 2.0 Hz, 2H), 7.68 (d, J= 8.4 Hz, 2H), 7.46 (d, J= 2.0 Hz, 2H), 7.33 (dd, J= 9.2, 2.4 Hz, 2H), 7.29 (t, J= 7.6 Hz, 8H), 7.17 (d, J= 8.4 Hz, 8 H), 7.07 (t, J= 8.4 Hz, 4H); 13C NMR (100 MHz, CDC13) delta 147.6, 145.6, 140.0, 139.4, 136.5, 133.6, 130.1, 129.3, 129.1, 127.6, 127.5, 127.4, 125.7, 125.3, 124.7, 124.4, 123.0, 119.6; LCMS (M+H)+ Calc'd for C56H4iN2 741.3269, found 741.3270. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
12.59% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; In N,N-dimethyl-formamide; at 90℃; | To a solution of [l,l'-biphenyl]-4,4'-diyldiboronic acid (0.65 g, 2.419 mmol) in DMF (2 mL), was added (S)-tert-butyl (l-(5-bromo-l-methyl-lH-imidazol-2-yl)- 2-methylpropyl)carbamate (1.688 g, 5.08 mmol), potassium phosphate tribasic (2.054 g, 9.68 mmol) and PdC dppf) (0.177 g, 0.242 mmol). The reaction mixture was degassed and heated to 90C for overnight. The volatile component was removed in vacuo. The resulting residue was dissolved in EtOAc (100 mL) and filtered through celite bed. The filtrate was washed with brine, dried over Na2S04and concentrated in vacuo. The crude material was purified by ISCO using 40 g Redisep silica column (MeOH:CHCi3, 3:97) and further purified by reverse phase prep HPLC to obtain di- tert-butyl (( 1 S, 1 'S)-(5,5'-([ 1 , 1 '-biphenyl]-4,4'-diyl)bis( 1 -methyl- 1 H-imidazole-5,2- diyl))bis(2-methylpropane-l,l-diyl))dicarbamate (0.2 g, 0.304 mmol, 12.59 % yield) as off white solid. NMR (DMSO-d6, delta = 2.50 ppm, 300 MHz): delta 7.81 (d, J=8.31 Hz, 4 H), 7.56 (d, J = 8.1 Hz ,4 H), 7.18 (s, 2 H), 7.04 (s, 2 H), 4.42 - 4.51 (m, 2 H), 3.83 (s, 6 H), 2.21 - 2.33 (m, 2 H), 1.39 (s, 18 H), 0.99 (d, J= 6.52 Hz, 6 H), 0.84 (d, J = 6.61 Hz, 6H). LCMS : (Condition-B12) Rt: 2.45 -200 Step i |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
47% | With potassium phosphate monohydrate; copper(II) acetate monohydrate; In dimethyl sulfoxide; at 40℃; for 24h;Sealed tube; | General procedure: An oven-dried 25 mL sealed tube with stir bar was charged with arylboronic acid (1 equiv.),2-amino pyridine (1 equiv.), Cu(OAc)2·H2O (1.2 equiv.), K3PO4·H2O(2 equiv.) and 3 or 5 mL of DMSO was added and closed the sealed tube. The reactionmixture was heated at the indicated temperature for 24 h. After the reaction finished, theproduct was extracted with ethyl acetate (5 × 3 mL). The organic layers werewashed with brine, dried over Na2SO4, and evaporated toyield the crude reaction mixture. The purification was done by combi flashmachine flash chromatography on silica gel (eluent: heptanes:EtOAc = 60:40). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,2-dimethoxyethane; water; for 12h;Reflux; | A mixture of 4,4-biphenyldiboronic acid (25mg, 0.10mmol) and 2,6-difluoro-3-iodopyridine (50mg, 0.21mmol) was added to a suspension of Pd(PPh3)4 (14mg, 0.012mmol) in 1,2-dimethoxyethane (4mL) and aqueous Na2CO3 (0.5mL, 2mol/L). The mixture was subsequently maintained at reflux for 12h, allowed to cool and then poured into H2O (10mL) and extracted with CH2Cl2 (3×30mL). The organic extracts were dried (MgSO4), concentrated in vacuo and the residue was purified by column chromatography (CH2Cl2/pentane=1:9, v/v) to give the product as a white powder (29mg, 76%). 1H NMR (400MHz, CDCl3): delta 8.03 (dd, 2H, J=7.9, 17.3), 7.75 (d, 4H, J=8.5), 7.64 (d, 4H, J=8.4), 6.96 (dd, 2H, J=2.9, 8.1). 19F NMR (376MHz, CDCl3): delta -69.8, -70.8. HRMS m/z calcd. for C22H12F4N2Na [M+Na+]: 403.0834, found: 403.0837. MP: 193-195C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,2-dimethoxyethane; water; for 14h;Reflux; | A mixture of 4,4-biphenyldiboronic acid (25mg, 0.10mmol) and 2,6-difluoro-4-iodopyridine (50mg, 0.21mmol) was added to a suspension of Pd (PPh3)4 (14mg, 0.012mmol) in 1,2-dimethoxyethane (4mL) and aqueous Na2CO3 (0.5mL, 2mol/L). The mixture was subsequently maintained at reflux for 14h, allowed to cool, poured into H2O (10mL), and extracted with CH2Cl2 (3×30mL). The organic extracts were dried (MgSO4), concentrated in vacuo, and the residue was purified by column chromatography (CH2Cl2/pentane=1:9, v/v) to give the product as a white powder (32mg, 82%). 1H NMR (400MHz, DMSO-d6): delta 8.00 (dd, 8H, J=8.5, 38.9), 7.65 (s, 4H). 19F NMR (376MHz, CDCl3): delta -68.6. MALDI-TOF-MS m/z calcd. for C22H12F4N2 [M+]: 380.094, found: 379.848. MP: 240-242C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In ethanol; water; toluene; at 80℃; for 18h;Inert atmosphere; | General procedure: The synthesis of 1,4-bis-(8-benzyloxyquinolin-5-yl)benzene 15 will be used as representative example for the synthesis of bis-8-tosyloxyquinolines 17. 5-Bromo-8-benzyloxyquinoline 14 (314 mg, 1 mmol, 1 equiv), benzene-1,4-diboronic acid (82.8 mg, 0.5 mmol, 0.5 equiv), sodium carbonate (217 mg, 2.05 mmol, 2.05 equiv) and tetrakis(triphenylphosphine)palladium(0) (35 mg, 0.06 mmol, 0.06 equiv) were added to a flask (50 mL). Meanwhile, a solvent mixture of toluene/ethanol/water (3/1/1, 15 mL/5 mL/5 mL) was degassed under argon atmosphere by a freeze-thaw procedure. The degassed solvent mixture was added to the reagents and the mixture was stirred for 18 hours at 80C under argon atmosphere. When the reaction was finished, the mixture was cooled and the crude product was extracted with CH2Cl2 (25 mL) and water (25 mL). The organic fraction was washed three times with water (25 mL), dried (MgSO4) and evaporated to obtain the crude product. Recrystallization from CHCl3 yielded 1,4-bis-(8-benzyloxyquinolin-5-yl)benzene 15 in 52% (141 mg, 0.26 mmol). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
29% | With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,4-dioxane; methanol; at 100℃; for 16h;Inert atmosphere; Schlenk technique; | General procedure: Starting material 1a (236 mg, 0.50 mmol) in dry 1,4-dioxane(2.00 mL) was placed under nitrogen atmosphere in a sinteredscrew-cap Schlenk tube and degassed with nitrogen(5 min). Then tetrakis(triphenylphosphane)palladium (0)(118 mg, 0.10 mmol, 10 mol%), Na2CO3 (132 mg,1.25 mmol), bisboronic acids 4 (0.55 mmol) and methanol(1.00 mL) were successively added (for experimental detailssee Table 3). The reaction mixture was stirred at 100 C for16 h. After cooling to room temperature (5 min, water bath)deionized water (10 mL) was added and the aqueous phasewas extracted with dichloromethane (3×10 mL, monitoredby TLC). The combined organic layers were dried (anhydroussodium sulfate) and filtered. After removal of the solvents in vacuo, the residue was absorbed onto celite andpurified by chromatography on silica gel (petroleum ether(boiling range 40-60 C)/ethyl acetate or dichloromethane)to give the bis(3-ethynyl quinoxaline thienyl) dumbbells 5. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,4-dioxane; water; at 100℃; | 1.2 g of 1-bromo-2,4-dibutoxybenzene was completely dissolved in an aqueous 1,4-dioxane solution (dioxane: water = 5: 1), and then 0.5 g of 2,4- Dimethoxyphenylboronic acid, 0.4 g of tetratriphenylphosphine palladium, 1.6 g of sodium carbonate, the mixed system was heated to 100 C under reflux overnight. After the reaction, the reaction solution was cooled to room temperature, the solvent was spin-dried, dissolved in dichloromethane, and extracted three times with water. The organic layer was dried over anhydrous Na2SO4, re-spinned and stirred, and separated by column chromatography to obtain monomer M25. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetrakis(triphenylphosphine) palladium(0); sodium carbonate; In 1,4-dioxane; water; at 100℃; | 1.5g of 4-bromo-2- (5-bromo-n-pentyloxy) -5-methoxybenzene was completely dissolved in an aqueous solution of 1,4-dioxane (dioxane: water = 5: 1) Then, 0.5 g of 2,4-dimethoxyphenylboronic acid, 0.4 g of tetratriphenylphosphine palladium, and 1.6 g of sodium carbonate were added, and the mixed system was heated to 100 C under reflux overnight. After the reaction, the reaction solution was cooled to room temperature, the solvent was spin-dried, dissolved in dichloromethane, and extracted three times with water. The organic layer was dried over anhydrous Na2SO4, re-spinned and stirred, and separated by column chromatography to obtain monomer M26. |
Tags: 4151-80-8 synthesis path| 4151-80-8 SDS| 4151-80-8 COA| 4151-80-8 purity| 4151-80-8 application| 4151-80-8 NMR| 4151-80-8 COA| 4151-80-8 structure
[ 881913-20-8 ]
(3-(Naphthalen-1-yl)phenyl)boronic acid
Similarity: 0.98
[ 491595-36-9 ]
(2'-Methyl-[1,1'-biphenyl]-4-yl)boronic acid
Similarity: 0.98
[ 870774-29-1 ]
(3-(Naphthalen-2-yl)phenyl)boronic acid
Similarity: 0.98
[ 881913-20-8 ]
(3-(Naphthalen-1-yl)phenyl)boronic acid
Similarity: 0.98
[ 491595-36-9 ]
(2'-Methyl-[1,1'-biphenyl]-4-yl)boronic acid
Similarity: 0.98
[ 870774-29-1 ]
(3-(Naphthalen-2-yl)phenyl)boronic acid
Similarity: 0.98
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :